Guizhi Fuling pill attenuates liver fibrosis in vitro and in vivo via inhibiting TGF-β1/Smad2/3 and activating IFN-γ/Smad7 signaling pathways

References

• Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37–55.
   PubMed Web of Science ®Google Scholar
• Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209–218.
   PubMed Web of Science ®Google Scholar
• Ye J, Lin Y, Yu Y, et al. LncRNA NEAT1/microRNA-129-5p/SOCS2 axis regulates liver fibrosis in alcoholic steatohepatitis. J Transl Med. 2020;18(1):445.
   PubMed Web of Science ®Google Scholar
• Blonsky JJ, Harrison SA. Review article: nonalcoholic fatty liver disease and hepatitis C virus–partners in crime. Aliment Pharmacol Ther. 2008;27(10):855–865.
   PubMed Web of Science ®Google Scholar
• Dong Z, Li S, Wang X, et al. lncRNA GAS5 restrains CCl 4-induced hepatic fibrosis by targeting miR-23a through the PTEN/PI3K/Akt signaling pathway. Am J Physiol Gastrointest Liver Physiol. 2019;316(4):G539–g50.
   PubMed Web of Science ®Google Scholar
• Kwon HJ, Won YS, Park O, et al. Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice. Hepatology. 2014;60(1):146–157.
   PubMed Web of Science ®Google Scholar
• Wang S, Fan X, Gao Y, et al. The Relationship Between Zinc Deficiency and Hepatocellular Carcinoma Associated with Hepatitis B Liver Cirrhosis: a 10-year Follow-up Study. Biol Trace Elem Res. 2022. DOI:10.1007/s12011-022-03156-z
   Web of Science ®Google Scholar
• Petitclerc L, Sebastiani G, Gilbert G, et al. Liver fibrosis: review of current imaging and MRI quantification techniques. J Magn Reson Imaging. 2017;45(5):1276–1295.
   PubMed Web of Science ®Google Scholar
• Urtasun R, Conde de la Rosa L, Nieto N. Oxidative and nitrosative stress and fibrogenic response. Clin Liver Dis. 2008;12(4):769–90, viii.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Kamiya A, Sumiyoshi H, et al. A Deactivation Factor of Fibrogenic Hepatic Stellate Cells Induces Regression of Liver Fibrosis in Mice. Hepatology. 2020;71(4):1437–1452.
   PubMed Web of Science ®Google Scholar
• Shajari S, Laliena A, Heegsma J, et al. Melatonin suppresses activation of hepatic stellate cells through ROR α-mediated inhibition of 5-lipoxygenase. J Pineal Res. 2015;59(3):391–401.
   PubMed Web of Science ®Google Scholar
• Fagone P, Mangano K, Pesce A, et al. Emerging therapeutic targets for the treatment of hepatic fibrosis. Drug Discov Today. 2016;21(2):369–375.
   PubMed Web of Science ®Google Scholar
• Takase T, Toyoda T, Kobayashi N, et al. Dietary iso-α-acids prevent acetaldehyde-induced liver injury through Nrf2-mediated gene expression. PloS one. 2021;16(2):e0246327.
   PubMed Web of Science ®Google Scholar
• Lestari N, Louisa M, Soetikno V, et al. Alpha Mangostin Inhibits the Proliferation and Activation of Acetaldehyde Induced Hepatic Stellate Cells through TGF-β and ERK 1/2 Pathways. J Toxicol. 2018;2018:5360496.
   PubMed Web of Science ®Google Scholar
• Chen L, Chen H, Yang Q, et al. Guizhi Fuling Capsule inhibits uterine fibroids growth by modulating Med12-mediated Wnt/beta-Catenin signaling pathway. J Ethnopharmacol. 2022;290:115115.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Xin G, Gong G, et al. Evaluation of Anti-Inflammatory Components of Guizhi Fuling Capsule, an Ancient Chinese Herbal Formula, in Human Umbilical Vein Endothelial Cells. Evidence-based complementary and alternative medicine: eCAM 2020. 2020;10(2):2029134.
   Google Scholar
• Zheng W, Li M, Wang Y, et al. Guizhi Fuling Capsule Exhibits Antidysmenorrhea Activity by Inhibition of Cyclooxygenase Activity. Evidence-based complementary and alternative medicine: eCAM 2020. 2020;23(4):8607931.
   Google Scholar
• Wang YR, Li N, Cao L, et al. Study on anti-inflammation and immunoloregulation effect of Guizhi Fuling capsule ingredients using high content screening. Zhongguo Zhong Yao Za Zhi. 2015;40(6):1005–1011.
   PubMedGoogle Scholar
• Lian Y, Zhu M, Chen J, et al. Characterization of a novel polysaccharide from Moutan Cortex and its ameliorative effect on AGEs-induced diabetic nephropathy. Int J Biol Macromol. 2021;176:589–600.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hu J, Zhuo Y, et al. Amygdalin improves microcirculatory disturbance and attenuates pancreatic fibrosis by regulating the expression of endothelin-1 and calcitonin gene-related peptide in rats. J Chin Med Assoc. 2018;81(5):437–443.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Zhang J, Deng W, et al. Bushen Yijing Decoction (BSYJ) exerts an anti-systemic sclerosis effect via regulating MicroRNA-26a /FLI1 axis. Bioengineered. 2021;12(1):1212–1225.
   PubMed Web of Science ®Google Scholar
• Ye Y, Wu W, Zheng J, et al. Role of long non-coding RNA-adducin 3 antisense RNA1 in liver fibrosis of biliary atresia. Bioengineered. 2022;13(3):6222–6230.
   PubMed Web of Science ®Google Scholar
• Xu XY, Geng Y, Xu HX, et al. Antrodia camphorata-Derived Antrodin C Inhibits Liver Fibrosis by Blocking TGF-Beta and PDGF Signaling Pathways. Front Mol Biosci. 2022;9:835508.
   PubMed Web of Science ®Google Scholar
• Zhu T, Zhang L, Li C, et al. The S100 calcium binding protein A11 promotes liver fibrogenesis by targeting TGF-beta signaling. J Genet Genomics. 2022. DOI:10.1016/j.jgg.2022.02.013.
   Web of Science ®Google Scholar
• Chen CC, Huang CY, Shiu LY, et al. Combinatory effects of current regimens and Guizhi Fuling Wan on the development of endometriosis. Taiwan J Obstet Gynecol. 2022;61(1):70–74.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Chen H, Li Y, et al. Transcriptome and biochemical analyses of rainbow trout (Oncorhynchus mykiss) RTG-2 gonadal cells in response to BDE-47 stress indicates effects on cell proliferation. Aquat Toxicol. 2022;245:106108.
   PubMed Web of Science ®Google Scholar
• Zhu YF, Wang R, Chen W, et al. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKepsilon. Acta Histochem. 2021;123(1):151653.
   PubMed Web of Science ®Google Scholar
• Bai Z, Liu W, He D, et al. Protective effects of autophagy and NFE2L2 on reactive oxygen species-induced pyroptosis of human nucleus pulposus cells. Aging (Albany NY). 2020;12(8):7534–7548.
   PubMedGoogle Scholar
• Zhang Y, Su N, Liu W, et al. Metabolomics Study of Guizhi Fuling Capsules in Rats With Cold Coagulation Dysmenorrhea. Front Pharmacol. 2021;12:764904.
   PubMed Web of Science ®Google Scholar
• Zhong X, Song Z, Ning Z, et al. Inhibition of Src improves cardiac fibrosis in AngII-induced hypertrophy by regulating the expression of galectin-3. Microvasc Res. 2022;104347. DOI:10.1016/j.mvr.2022.104347
   PubMed Web of Science ®Google Scholar
• Liu N, Guan Y, Zhou C, et al. Pulmonary and Systemic Toxicity in a Rat Model of Pulmonary Alveolar Proteinosis Induced by Indium-Tin Oxide Nanoparticles. Int J Nanomedicine. 2022;17:713–731.
   PubMed Web of Science ®Google Scholar
• Song L, Chen TY, Zhao XJ, et al. Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose-induced liver fibrosis through suppressing miR-34a/Sirt1/p53 and TGF-β1/Smads signalling. Br J Pharmacol. 2019;176(11):1619–1634.
   PubMed Web of Science ®Google Scholar
• Weng H, Mertens PR, Gressner AM, et al. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads. J Hepatol. 2007;46(2):295–303.
   PubMed Web of Science ®Google Scholar
• Wu X, Wu X, Ma Y, et al. CUG-binding protein 1 regulates HSC activation and liver fibrogenesis. Nat Commun. 2016;7(1):13498.
   PubMedGoogle Scholar
• Wang P, Cui Y, Wang J, et al. Mesenchymal stem cells protect against Acetaminophen hepatotoxicity by secreting regenerative cytokine hepatocyte growth factor. Stem Cell Res Ther. 2022;13(1):94.
   PubMed Web of Science ®Google Scholar
• Abassa KK, Xiao XP, Zhou HX, et al. FcGBP and VCAM-1 are ponderable biomarkers for differential diagnosis of alcoholic liver cirrhosis. Drug Alcohol Depend. 2022;233:109377.
   PubMed Web of Science ®Google Scholar
• Wang R, Song F, Li S, et al. Salvianolic acid A attenuates CCl(4)-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways. Drug Des Devel Ther. 2019;13:1889–1900.
   PubMed Web of Science ®Google Scholar
• Cai FF, Bian YQ, Wu R, et al. Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis. Biomed Pharmacothe. 2019;114:108863.
   PubMed Web of Science ®Google Scholar
• Hsu WH, Liao SC, Chyan YJ, et al. Graptopetalum paraguayense Inhibits Liver Fibrosis by Blocking TGF-β Signaling In Vivo and In Vitro. Int J Mol Sci. 2019;20(10) :2592.
   Web of Science ®Google Scholar
• Dong S, Cai FF, Chen QL, et al. Chinese herbal formula Fuzheng Huayu alleviates CCl(4)-induced liver fibrosis in rats: a transcriptomic and proteomic analysis. Acta Pharmacol Sin. 2018;39(6):930–941.
   PubMed Web of Science ®Google Scholar
• Yu X, Elfimova N, Muller M, et al. Autophagy-related activation of hepatic stellate cells reduces cellular miR-29a by promoting its vesicular secretion. Cell Mol Gastroenterol Hepatol. 2022. DOI:10.1016/j.jcmgh.2022.02.013.
   Web of Science ®Google Scholar
• Meng D, Li Z, Wang G, et al. Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomed Pharmacothe. 2018;108:1617–1627.
   PubMed Web of Science ®Google Scholar
• Feriani A, Tir M, Gómez-Caravaca AM, et al. Zygophyllum album leaves extract prevented hepatic fibrosis in rats, by reducing liver injury and suppressing oxidative stress, inflammation, apoptosis and the TGF-β1/Smads signaling pathways. Exploring of bioactive compounds using HPLC-DAD-ESI-QTOF-MS/MS. Inflammopharmacology. 2020;28(6):1735–1750.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhang C, Meng X, et al. Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and beta-Catenin Signaling Pathway. Front Physiol. 2022;13:792182.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li R, Hu N, et al. Baihe Wuyao decoction ameliorates CCl(4)-induced chronic liver injury and liver fibrosis in mice through blocking TGF-β1/Smad2/3 signaling, anti-inflammation and anti-oxidation effects. J Ethnopharmacol. 2020;263:113227.
   PubMed Web of Science ®Google Scholar
• Ramalingam TR, Gieseck RL, Acciani TH, et al. Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-γ. J Pathol. 2016;239(3):344–354.
   PubMed Web of Science ®Google Scholar
• Jeong WI, Park O, Radaeva S, et al. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology. 2006;44(6):1441–1451.
   PubMed Web of Science ®Google Scholar
• Cast A, Kumbaji M, D’Souza A, et al. Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2019;3(8):1036–1049.
   PubMed Web of Science ®Google Scholar
• Liu Y, Huang H, Yuan B, et al. Suppression of CUGBP1 inhibits growth of hepatocellular carcinoma cells. Clin Invest Med. 2014;37:E10–8.
   PubMed Web of Science ®Google Scholar
• Huang Q, Zhang X, Bai F, et al. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways. Int Immunopharmacol. 2019;66:41–51.
   PubMed Web of Science ®Google Scholar